| Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women (NCT03834571) | AIDS Malignancy Consortium | 2022-05-31 |
| Clinical Evaluation of Detection of High Risk HPV in Urine (NCT05210348) | Peking University People's Hospital | 2021-09-15 |
| Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer (NCT03738228) | National Cancer Institute (NCI) | 2019-01-07 |
| HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma (NCT03742869) | Lei Li | 2018-11-10 |
| Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer (NCT02921269) | National Cancer Institute (NCI) | 2017-03-10 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (NCT02466971) | National Cancer Institute (NCI) | 2016-05-10 |
| Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer (NCT02562729) | Shanghai Gynecologic Oncology Group | 2015-09-01 |
| Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer (NCT02257528) | National Cancer Institute (NCI) | 2015-05-18 |
| Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer (NCT02140021) | M.D. Anderson Cancer Center | 2014-10-27 |
| Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers (NCT02020707) | Mayo Clinic | 2014-02-24 |
| MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer (NCT01992861) | University of Washington | 2014-02-14 |
| Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer (NCT01649089) | GOG Foundation | 2013-06-05 |
| Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer (NCT01693783) | National Cancer Institute (NCI) | 2012-12-03 |
| Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer (NCT01711515) | National Cancer Institute (NCI) | 2012-10-01 |
| Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer (NCT01414608) | GOG Foundation | 2012-01-09 |
| Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer (NCT02880007) | Institut de Cancérologie de Lorraine | 2011-06-06 |
| Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01266460) | Gynecologic Oncology Group | 2011-05-23 |
| Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer (NCT01295502) | Gynecologic Oncology Group | 2011-04-04 |
| Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01267253) | Gynecologic Oncology Group | 2011-04-04 |
| Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer (NCT01281852) | National Cancer Institute (NCI) | 2011-03-14 |
| Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01266447) | National Cancer Institute (NCI) | 2011-02-01 |
| Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer (NCT01048853) | M.D. Anderson Cancer Center | 2010-04-15 |
| Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery (NCT01101451) | GOG Foundation | 2010-04-12 |
| Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery (NCT01026792) | National Cancer Institute (NCI) | 2009-12-01 |
| Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer (NCT00803062) | National Cancer Institute (NCI) | 2009-04-01 |
| Ixabepilone to Treat Cervical Cancer (NCT00924066) | National Cancer Institute (NCI) | 2008-11-01 |
| FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer (NCT00559377) | National Cancer Institute (NCI) | 2007-11-01 |
| Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer (NCT00054444) | Gynecologic Oncology Group | 2007-09-01 |
| Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer (NCT00416455) | National Cancer Institute (NCI) | 2007-09-01 |
| Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery (NCT00389974) | National Cancer Institute (NCI) | 2007-01-01 |
| ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT00309959) | Gynecologic Oncology Group | 2006-11-01 |
| Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer (NCT00369122) | National Cancer Institute (NCI) | 2006-08-11 |
| Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer (NCT00262821) | National Cancer Institute (NCI) | 2006-02-01 |
| Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer (NCT00104910) | Gynecologic Oncology Group | 2005-01-01 |
| Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer (NCT00070317) | Gynecologic Oncology Group | 2004-06-01 |
| Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer (NCT00068549) | Gynecologic Oncology Group | 2003-10-01 |
| Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix (NCT00064077) | Gynecologic Oncology Group | 2003-05-01 |
| Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer (NCT00057863) | National Cancer Institute (NCI) | 2003-01-01 |
| Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT00039442) | Gynecologic Oncology Group | 2002-04-29 |
| Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia (NCT00017004) | Gynecologic Oncology Group | 2001-08-01 |
| Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442) | Gynecologic Oncology Group | 1992-06-01 |